MapLight Therapeutics (MPLT) Shares Issued (2024 - 2025)
MapLight Therapeutics (MPLT) reported Shares Issued of $852663.0 for Q4 2025, down 10.87% on a YoY basis from $956667.0 in Q4 2024, and little changed sequentially from $852954.0 in Q3 2025.
MapLight Therapeutics (MPLT) Shares Issued (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Shares Issued data on file, last reported at $852663.0 in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued fell 10.87% year-over-year to $852663.0; the trailing twelve-month figure through Dec 2025 stood at $852663.0 (down 10.87% YoY), and the FY2025 full-year result was $852663.0, down 10.87% from the prior year.
- Shares Issued was little changed at $852663.0 in Q4 2025, from $852954.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $956667.0 in Q4 2024 to a low of $852663.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 88,604.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.44 Mn |
| 10 | MapLight Therapeutics | 314.07 Mn | 314.07 Mn | - | 852,663.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 852,663.00 |
| Dec 31, 2025 | 852,663.00 |
| Sep 30, 2025 | 852,954.00 |
| Sep 30, 2025 | 852,954.00 |
| Dec 31, 2024 | 956,667.00 |
| Dec 31, 2024 | 956,667.00 |